Esposito S, Leone S, Noviello S, Fiore M, Ianniello F, Felaco F M, Romagnoli F, Sarli E
Department of Infectious Diseases, Second University of Naples, Naples, Italy.
Diabet Med. 2008 Aug;25(8):979-84. doi: 10.1111/j.1464-5491.2008.02507.x.
To conduct a multicentre observational study to describe management of foot infections in diabetes in the out-patient setting in Italy.
Ten centres equally distributed nationwide were asked to collect, by means of a spreadsheet (Access/Excel Microsoft program), data concerning 30 consecutive diabetic patients with foot infections deemed suitable for antibiotic treatment in the out-patient setting. Centres with > or = 5 years' experience of out-patient management were selected. Data from 271 consecutive patients treated as out-patients were collected and analysed by the central coordinator. Statistical analysis was performed using the SPSS statistical software package.
Lesions were mainly located at the toes and midfoot (33.6 and 30.2%, respectively); 63 (23.2%) patients had multiple ulcers. Seventy (25.8%) patients also had concomitant osteomyelitis. Three hundred and four pathogens, including Gram-positive and Gram-negative aerobes and anaerobes, were isolated in 219/271 patients (80.8%) by culturing debrided tissue (71.2%) or purulent material (28.8%). Infections were polymicrobial in 33.8% of patients. The most common pathogens were Staphylococcus aureus (27.3%) and Pseudomonas spp. (20.4%); enterobacteriaceae, enterococci, streptococci and anaerobes accounted for 11.5, 7.6, 6.9 and 1.9%, respectively. Antibiotics were frequently administered by parenteral route and frequently in combination. Piperacillin/tazobactam was the parenteral antibiotic most frequently utilized (21.1%). Cure/improvement was observed in 93.4% of patients.
Foot ulcers in diabetes are common and serious; the aetiology is often polymicrobial, often including S. aureus and Pseudomonas spp. Treatment in the out-patient setting is safe and effective, and penicillins together with beta-lactamase inhibitors and fluoroquinolones are the most frequent choice.
开展一项多中心观察性研究,以描述意大利门诊环境下糖尿病足部感染的管理情况。
在全国范围内平均分布的10个中心被要求通过电子表格(微软Access/Excel程序)收集30例连续的适合门诊抗生素治疗的糖尿病足部感染患者的数据。选择具有5年及以上门诊管理经验的中心。由中央协调员收集并分析271例连续门诊治疗患者的数据。使用SPSS统计软件包进行统计分析。
病变主要位于脚趾和足中部(分别为33.6%和30.2%);63例(23.2%)患者有多处溃疡。70例(25.8%)患者还伴有骨髓炎。通过对清创组织(71.2%)或脓性物质(28.8%)进行培养,在219/271例患者(80.8%)中分离出304种病原体,包括革兰氏阳性和革兰氏阴性需氧菌及厌氧菌。33.8%的患者感染为多微生物感染。最常见的病原体是金黄色葡萄球菌(27.3%)和假单胞菌属(20.4%);肠杆菌科、肠球菌、链球菌和厌氧菌分别占11.5%、7.6%、6.9%和1.9%。抗生素常通过胃肠外途径给药且常联合使用。哌拉西林/他唑巴坦是最常使用的胃肠外抗生素(21.1%)。93.4%的患者观察到治愈/改善。
糖尿病足部溃疡常见且严重;病因通常为多微生物感染,常包括金黄色葡萄球菌和假单胞菌属。门诊治疗安全有效,青霉素联合β-内酰胺酶抑制剂和氟喹诺酮类是最常选用的药物。